Skip to main content
. Author manuscript; available in PMC: 2022 Oct 15.
Published in final edited form as: Neuroimage. 2022 Jul 13;260:119474. doi: 10.1016/j.neuroimage.2022.119474

Table 2.

We employ a diverse set of acquired evaluation data, spanning across imaging modalities, MRI contrasts, and resolution (res.), where 2D indicates stacks of slice-wise acquisitions. Each individual dataset is divided into a small validation (val.) and a larger test set. For further details see Section 3.4.2.

Dataset Modality Res. (mm3) Val. Test
IXI T1w MRI 0.9×0.9×1.2 0 48
T2w MRI 0.9×0.9×1.2 2 48
PDw MRI 0.9×0.9×1.2 2 48
MRA 0.5×0.5×0.8 2 48
DWI 1.8×1.8×2.0 0 32
FSM T1w MPRAGE 1.0×1.0×1.0 0 38
T2w 3D-SPACE 1.0×1.0×1.0 2 34
PDw 3D-FLASH 1.0×1.0×1.0 2 30
qT1 MP2RAGE 1.0×1.0×1.0 2 30
ASL T1w MPRAGE 1.0×1.0×1.0 2 41
PCASL 2D-EPI 3.4×3.4×5.0 2 41
QIN T1w 2D-FLASH 0.4×0.4×6.0 2 52
T2-FLAIR 2D-FSE 0.4×0.4×6.0 2 15
T2w 2D-FSE 1.0×1.0×5.0 2 37
Infant T1w MPRAGE 1.0×1.0×1.0 0 16
CIM FDG PET 2.0×2.0×2.0 0 20
CT 0.6×0.6×1.5 0 20